礼来：第二季度营收155.6亿美元 同比增长38%

Core Viewpoint - Eli Lilly reported a revenue of $15.56 billion for Q2 2025, representing a year-over-year growth of 38% [2] - The company has raised its full-year revenue guidance to between $60 billion and $62 billion, up from the previous estimate of $58 billion to $61 billion [2] Summary by Category - Financial Performance - Q2 2025 revenue reached $15.56 billion, marking a 38% increase compared to the same quarter last year [2] - Full-year revenue forecast adjusted to $60 billion to $62 billion, an increase from the prior range of $58 billion to $61 billion [2]